4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-023021
Director acquired 379 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dubin Glenn Director | 2022-04-04 | Grant or award | +379 | $26.46 | $10,028 | 873 | D |
Loading xslF345X03/doc4.xml…